相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens
Hillary A. Vanderven et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays
Qiang Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova et al.
BLOOD (2020)
Lessons for COVID-19 Immunity from Other Coronavirus Infections
Alan Sariol et al.
IMMUNITY (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
Bicheng Zhang et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Considering how biological sex impacts immune responses and COVID-19 outcomes
Eileen P. Scully et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
Laura A. VanBlargan et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status
Xian Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Using the margins command to estimate and interpret adjusted predictions and marginal effects
Richard Williams
STATA JOURNAL (2012)
An immunosuppressed Syrian golden hamster model for SARS-CoV infection
Scott R. Schaecher et al.
VIROLOGY (2008)
Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis
Scott R. Schaecher et al.
JOURNAL OF VIROLOGY (2007)
The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles
Scott R. Schaecher et al.
JOURNAL OF VIROLOGY (2007)
分享论文
